Perimenopause hair loss: why your hair is thinning and what the evidence says about treatment
Hair changes in perimenopause are real, hormonally driven, and often partially reversible. Here's the mechanism behind them and an honest look at every treatment option that has genuine evidence behind it.
You notice it in the shower drain first. Then in your brush. Then in the mirror — a hairline that looks different, a part that looks wider, a ponytail that feels thinner in your hand. This is real, and it is not anxiety.
Two types of hair loss become more common in perimenopause: telogen effluvium (diffuse shedding triggered by hormonal stress) and female pattern hair loss (FPHL, a gradual thinning at the crown and frontal hairline driven by androgenic changes). Both are linked to the hormonal shift — falling estrogen, a relative rise in androgens. The good news: neither is inevitable, and effective treatments exist. Minoxidil (topical or oral) is first-line with solid evidence. Spironolactone adds meaningful benefit for FPHL. Estrogen-based HRT helps many women, particularly those whose hair loss is tied clearly to the hormonal transition. Iron deficiency is a frequently missed contributor — check ferritin.
Hair loss does not appear on the standard lists of perimenopause symptoms the way hot flashes do, which leaves many women confused about what's causing it and who to see. Your gynecologist might not think to ask. Your dermatologist might not connect it to the hormonal transition. You end up with shampoo recommendations when what you actually needed was a full picture.
What's happening hormonally
Hair grows in a cycle: a long growth phase (anagen), a brief transition (catagen), and a resting phase (telogen) before the hair sheds and a new one starts. Estrogen extends the anagen phase — it's one reason pregnant women often have unusually thick hair and then shed considerably after delivery when estrogen drops. In perimenopause, fluctuating and declining estrogen means shorter anagen phases and more follicles entering telogen simultaneously.
Simultaneously, as estrogen falls, the ratio of androgens to estrogen shifts. Even without any rise in absolute androgen levels, the relative androgenic effect on scalp follicles increases. Androgenic hair loss (female pattern hair loss, FPHL) is driven by dihydrotestosterone (DHT), which shrinks genetically susceptible follicles over time — typically at the crown and frontal hairline, rarely the nape.
The two main types of perimenopausal hair loss
Telogen effluvium
Telogen effluvium is diffuse shedding across the whole scalp — not a receding hairline, but a general thinning and increased daily shedding. It's often triggered by a hormonal shock (which perimenopausal fluctuations qualify as), nutritional deficiency, major illness, surgery, or extreme stress. It can look alarming quickly because many follicles shift to telogen at the same time, then shed two to three months later. The good news is it's usually self-limiting. Once the trigger resolves or stabilizes, the hair typically regrows. The bad news is "stabilize" can mean years in perimenopause.
Female pattern hair loss (FPHL)
FPHL is a gradual, progressive process. It tends to present as widening of the part and diffuse thinning at the crown, with the hairline generally preserved. It's genetic but triggered and accelerated by the androgenic shift of menopause. Unlike telogen effluvium, FPHL does not reverse on its own — it requires treatment to slow or stop it, and regrowth requires sustained intervention.
Many women have both simultaneously: FPHL that's been quiet for years becomes apparent when a layer of telogen effluvium is added on top.
What actually works: the evidence-based options
Minoxidil
Minoxidil is the only topical treatment for hair loss with strong FDA approval for women. It works by prolonging the anagen phase and increasing blood flow to follicles. It doesn't address the hormonal root cause — it manages the consequence. Results require 3–6 months of consistent use before they're visible, and the effect is maintained only with continued use.
Both 2% and 5% topical formulations are approved for women; the 5% solution shows modestly better results in trials. Oral minoxidil at low doses (0.25–2.5 mg/day) has become increasingly used by dermatologists for women with FPHL, with a 2024 study showing it superior to topical at equivalent effect sizes with less scalp irritation. The oral form requires a prescription and monitoring for side effects (fluid retention, rare unwanted facial hair at higher doses).
Spironolactone
Spironolactone is an anti-androgen that blocks androgen receptors at the follicle. It's been used off-label for FPHL for decades, and a 2025 randomized controlled trial confirmed it adds meaningful benefit to topical minoxidil in women with FPHL — not as a replacement but as an addition. It requires a prescription and is typically dosed at 50–200 mg/day. It can lower blood pressure, and it's not appropriate for women who are trying to conceive. It's particularly worth discussing if your hair loss is accompanied by other signs of androgen excess (acne, hirsutism) or if your labs show elevated androgens.
HRT (hormone therapy)
This one is more nuanced. Estrogen supports the hair cycle; adding systemic estrogen via HRT can help, particularly in women whose hair loss began clearly with the hormonal transition. But not all HRT is equal for hair. Progestins with high androgenic activity (like levonorgestrel, norethindrone) can worsen FPHL. Bioidentical micronized progesterone and low-androgenicity synthetic progestins are generally considered hair-friendlier choices. If you're starting HRT and hair loss is a concern, the specific progestin component matters — worth discussing explicitly with a menopause-specialist.
Iron: the frequently missed piece
Iron deficiency — specifically low serum ferritin — is a common, treatable, and often overlooked contributor to hair loss. The association is well-established: ferritin below 30 ng/mL is linked to increased telogen shedding even without frank anemia. Perimenopausal women with heavy or erratic periods are at particular risk. A simple blood test (ferritin, not just hemoglobin) will tell you whether this is a factor. Iron supplementation, if deficient, can meaningfully improve shedding.
What doesn't work (or barely works)
- Biotin supplements: evidence for hair regrowth is weak unless you have a documented biotin deficiency, which is uncommon. Popularized more by marketing than by trials.
- "Hair growth" shampoos and serums: mostly cosmetic effects. Caffeine shampoo has minor evidence for slowing shedding but is not a treatment.
- Collagen supplements: nutritional support for hair health in theory, but no strong evidence for reversing hormonally driven loss.
- Avoiding tight hairstyles: sensible for traction alopecia, different from FPHL or telogen effluvium — won't reverse either.
When to see a specialist, and which one
A dermatologist (preferably one who sees a lot of women's hair loss) is the right specialist for a formal diagnosis — they can do a scalp examination, pull test, and trichoscopy (dermoscopy of the scalp) to distinguish FPHL from telogen effluvium, and rule out other causes like alopecia areata or scarring alopecia. A board-certified menopause specialist or gynecologist should be in the picture if you're also managing other perimenopausal symptoms and considering HRT. The two conversations often benefit from coordination.
A reasonable baseline blood panel: ferritin, TSH (thyroid — hypothyroidism causes diffuse hair loss and is common in this age group), CBC, and hormone levels if not recently checked. Your primary care physician or gynecologist can order these.
Frequently asked questions
Will my hair grow back after perimenopause?+–
It depends on the type. Telogen effluvium (diffuse shedding triggered by hormonal stress) is usually self-limiting and the hair typically regrows once the trigger stabilizes — though this can take time. Female pattern hair loss (FPHL) is a progressive process that does not reverse on its own; it requires treatment to slow or maintain. Treatment started earlier generally produces better results.
What's the best treatment for perimenopause hair loss?+–
Minoxidil is the best-evidenced starting point — topical 5% or oral at low dose. For women with clear FPHL, adding spironolactone significantly improves outcomes. If hair loss is tied clearly to the hormonal transition and you have other perimenopausal symptoms, HRT (with an appropriate progestin choice) can help. Checking ferritin and treating iron deficiency is often the overlooked step that makes everything else work better.
Does HRT stop perimenopause hair loss?+–
For some women, yes — particularly when hair loss began clearly with the hormonal transition and is related to declining estrogen. Estrogen supports the anagen (growth) phase of the hair cycle. However, the specific progestin in the HRT regimen matters: progestins with high androgenic activity can worsen FPHL. Discuss this directly with a menopause-specialist when choosing a regimen.
Is hair loss in perimenopause permanent?+–
Telogen effluvium shedding is usually not permanent. FPHL, if left untreated, is progressive — it won't spontaneously reverse. But 'permanent' overstates the prognosis for most women who get appropriate treatment: minoxidil, spironolactone, and/or HRT can halt progression and, in many cases, stimulate meaningful regrowth.
Could something other than perimenopause be causing my hair loss?+–
Yes, and it's worth ruling out: hypothyroidism (extremely common in women over 40, causes diffuse thinning), iron deficiency, alopecia areata (patchy loss, autoimmune), and scalp conditions. A simple blood test (TSH, ferritin, CBC) catches most of these. Don't assume hormones are the only cause before checking.
This article is educational and not medical advice. Talk to a qualified clinician about your situation.